Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:LUCD NASDAQ:POCI NASDAQ:RXST NASDAQ:SMTI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLUCDLucid Diagnostics$1.05-1.9%$1.04$0.90▼$1.63$217.28M1.071.68 million shs647,419 shsPOCIPrecision Optics$5.14+0.8%$5.08$3.55▼$6.15$55.82M0.3236,118 shs45,132 shsRXSTRxSight$5.17+7.3%$5.68$4.48▼$13.65$199.53M1.151.29 million shs1.73 million shsSMTISanara MedTech$24.27+2.9%$21.53$16.05▼$35.95$216.18M1.1865,544 shs36,746 shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLUCDLucid Diagnostics-1.87%+2.44%+1.94%-7.89%-4.55%POCIPrecision Optics+0.78%0.00%-6.55%+20.37%+4.47%RXSTRxSight+7.26%-2.64%-1.34%-22.14%-60.59%SMTISanara MedTech+2.88%+6.03%+10.72%+40.78%-15.76%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLUCDLucid Diagnostics$1.05-1.9%$1.04$0.90▼$1.63$217.28M1.071.68 million shs647,419 shsPOCIPrecision Optics$5.14+0.8%$5.08$3.55▼$6.15$55.82M0.3236,118 shs45,132 shsRXSTRxSight$5.17+7.3%$5.68$4.48▼$13.65$199.53M1.151.29 million shs1.73 million shsSMTISanara MedTech$24.27+2.9%$21.53$16.05▼$35.95$216.18M1.1865,544 shs36,746 shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLUCDLucid Diagnostics-1.87%+2.44%+1.94%-7.89%-4.55%POCIPrecision Optics+0.78%0.00%-6.55%+20.37%+4.47%RXSTRxSight+7.26%-2.64%-1.34%-22.14%-60.59%SMTISanara MedTech+2.88%+6.03%+10.72%+40.78%-15.76%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceLUCDLucid Diagnostics 2.60Moderate Buy$4.19298.81% UpsidePOCIPrecision Optics 1.00SellN/AN/ARXSTRxSight 1.93Reduce$9.4482.68% UpsideSMTISanara MedTech 2.60Moderate Buy$34.0040.09% UpsideCurrent Analyst Ratings BreakdownLatest POCI, RXST, SMTI, and LUCD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/17/2026SMTISanara MedTech Freedom CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy6/11/2026RXSTRxSight Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)6/10/2026SMTISanara MedTech Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold6/8/2026LUCDLucid Diagnostics Ascendiant Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$9.00 ➝ $9.256/5/2026POCIPrecision Optics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/22/2026RXSTRxSight Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/15/2026LUCDLucid Diagnostics Maxim GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$3.00 ➝ $2.005/15/2026LUCDLucid Diagnostics BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$2.505/12/2026SMTISanara MedTech Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell5/7/2026RXSTRxSight Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/7/2026RXSTRxSight Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetEqual Weight$11.00 ➝ $9.00(Data available from 7/2/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookLUCDLucid Diagnostics$4.71M45.27N/AN/A($0.31) per share-3.39POCIPrecision Optics$19.09M2.95N/AN/A$1.60 per share3.21RXSTRxSight$134.48M1.59N/AN/A$6.70 per share0.77SMTISanara MedTech$103.12M2.16$0.61 per share39.68$0.67 per share36.22Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateLUCDLucid Diagnostics-$58.01M-$0.47N/AN/AN/A-876.72%N/A-116.26%8/12/2026 (Estimated)POCIPrecision Optics-$5.78M-$0.63N/AN/AN/A-17.03%-37.47%-19.96%N/ARXSTRxSight-$38.94M-$1.13N/AN/AN/A-36.58%-17.01%-15.12%8/6/2026 (Estimated)SMTISanara MedTech-$37.56M-$3.77N/AN/AN/A-31.23%-3.19%-0.56%8/12/2026 (Estimated)Latest POCI, RXST, SMTI, and LUCD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2026Q1 2026LUCDLucid Diagnostics-$0.05-$0.07-$0.02-$0.17$1.38 million$1.26 million5/13/2026Q3 2026POCIPrecision OpticsN/A-$0.01N/A-$0.01N/A$8.71 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthLUCDLucid DiagnosticsN/AN/AN/AN/AN/APOCIPrecision OpticsN/AN/AN/AN/AN/ARXSTRxSightN/AN/AN/AN/AN/ASMTISanara MedTechN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioLUCDLucid DiagnosticsN/A1.071.05POCIPrecision Optics0.042.101.74RXSTRxSightN/A10.208.93SMTISanara MedTech6.592.282.05Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipLUCDLucid Diagnostics74.01%POCIPrecision Optics13.71%RXSTRxSight78.78%SMTISanara MedTech8.10%Insider OwnershipCompanyInsider OwnershipLUCDLucid Diagnostics6.90%POCIPrecision Optics14.40%RXSTRxSight10.05%SMTISanara MedTech42.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableLUCDLucid Diagnostics70203.07 million189.06 millionNo DataPOCIPrecision Optics8010.94 million9.37 millionNot OptionableRXSTRxSight22041.40 million37.24 millionOptionableSMTISanara MedTech609.16 million5.32 millionNot OptionablePOCI, RXST, SMTI, and LUCD HeadlinesRecent News About These CompaniesSanara MedTech (SMTI) Stock Gets Fair Value Bump As Analysts Back Wound Care GrowthJune 23, 2026 | finance.yahoo.comSanara MedTech Earnings Call Signals Profitable GrowthJune 12, 2026 | theglobeandmail.comSanara MedTech (SMTI) Q1 2026 Earnings TranscriptJune 2, 2026 | fool.comHow The Sanara MedTech (SMTI) Narrative Is Shifting As The US$34 Target Stays PutMay 23, 2026 | finance.yahoo.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTIMay 21, 2026 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTIMay 19, 2026 | globenewswire.comSanara MedTech Inc (SMTI) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ...May 14, 2026 | finance.yahoo.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTIMay 14, 2026 | prnewswire.comSanara MedTech: From Cash Burner To Profitable GrowthMay 14, 2026 | seekingalpha.comSanara MedTech Inc (SMTI) Q1 2026 Earnings Report Preview: What To ExpectMay 13, 2026 | finance.yahoo.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTIMay 12, 2026 | globenewswire.comSanara MedTech Inc. (SMTI) Q1 2026 Earnings Call TranscriptMay 12, 2026 | seekingalpha.comSanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited)May 11, 2026 | globenewswire.comSMTI Investors Have Opportunity to Join Sanara MedTech Inc. Fraud Investigation with the Schall Law FirmMay 7, 2026 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTIMay 7, 2026 | prnewswire.comHow Sanara MedTech (SMTI) Is Reframing Its Growth Story Around A Steady US$34 TargetMay 5, 2026 | finance.yahoo.comSanara MedTech (SMTI) Q4 2025 Earnings TranscriptMay 4, 2026 | fool.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTIApril 30, 2026 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTIApril 28, 2026 | globenewswire.comWhat Makes Sanara Medtech (SMTI) A Compelling Risk-Reward Opportunity?April 23, 2026 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePOCI, RXST, SMTI, and LUCD Company DescriptionsLucid Diagnostics NASDAQ:LUCD$1.05 -0.02 (-1.87%) Closing price 07/1/2026 04:00 PM EasternExtended Trading$1.06 +0.00 (+0.48%) As of 07/1/2026 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.Precision Optics NASDAQ:POCI$5.14 +0.04 (+0.78%) Closing price 07/1/2026 04:00 PM EasternExtended Trading$5.07 -0.07 (-1.36%) As of 07/1/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.RxSight NASDAQ:RXST$5.17 +0.35 (+7.26%) Closing price 07/1/2026 04:00 PM EasternExtended Trading$5.15 -0.02 (-0.39%) As of 07/1/2026 06:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.Sanara MedTech NASDAQ:SMTI$24.27 +0.68 (+2.88%) Closing price 07/1/2026 04:00 PM EasternExtended Trading$24.26 -0.02 (-0.06%) As of 07/1/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks AirJoule Unveils Prime System, Clearing Path to Commercialization Comcast’s NBCUniversal Split Puts Broadband Back in Focus Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets Ouster Is Breaking Out as a Physical AI Leader: Here's What's Driving the Move Meta’s WhatsApp Shakeup Could Put India at the Center of Its Next Growth Push Hershey Stock May Be Near a Sweet Spot as Cocoa Pressure Eases Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
